eIF-2. These events lead to a limitation in eIF-2 function, 3 Corresponding author which facilitates the binding of initiator tRNA met to the initiating ribosomal subunit. Thus, activation of PKR TAR RNA binding protein (TRBP) belongs to an triggers a series of events that culminate in inhibition of RNA binding protein family that includes the doubleprotein synthesis (reviewed in Samuel, 1993) . stranded RNA-activated protein kinase (PKR), DrosoInhibition of translation is used as one defense by cells phila Staufen and Xenopus xlrbpa. One member of this against viral infections. Indeed, PKR serves an antiviral family, PKR, is a serine/threonine kinase which has function in affecting the efficiency with which viral anti-viral and anti-proliferative effects. In this study mRNAs are translated (Samuel, 1991) . Not unexpectedly, we show that TRBP is a cellular down-regulator of some viruses have evolved means for escaping PKR-PKR function. Assaying expression from an infectious mediated inhibition. Examples of virus escape strategies HIV-1 molecular clone, we found that PKR inhibited include the expression of dsRNA binding proteins viral protein synthesis and that over-expression of (Whitaker-Dowling and Youngner, 1984 ; Imani and TRBP effectively countered this inhibition. In intraJacobs, 1988), synthesis of viral RNAs that inhibit PKR cellular and in cell-free assays we show that TRBP activation (Kitajewiski et al., 1986; O'Malley et al. 1986 ), directly inhibits PKR autophosphorylation through sequestration of PKR (Dubois and ) an RNA binding-independent pathway. Biologically, and/or induction of its degradation (Black et al., 1989) , TRBP serves a growth-promoting role; cells that overproduction of substrates with structural similarity to eIF-2 express TRBP exhibit transformed phenotypes. Our (Davies et al., 1992) and activation of cellular inhibitors results demonstrate the oncogenic potential of TRBP of PKR (Lee,T.G. et al., 1990) . Studies on these virusand are consistent with the notion that intracellular cell interplays have helped to illustrate and to elucidate Chong et al., 1992; Koromilas et al., 1992; Dever et al., 1993; Lee,S.B. et al., 1993; . Gene expression is regulated at many levels, including Recent evidence supports the critical contributions of transcription (initiation and/or elongation), mRNA stability translational control in regulating cellular proliferation and translation. Translational control is one important step (reviewed in Sonenberg, 1993) . Perturbing the homeostatic in controlling the abundance of many essential and highly balance of translation can probably tip the cell towards expressed proteins (reviewed in Kaufman, 1994) . Initiation either transformation or programed cell death. Evidence of the translation of mRNAs is believed to be a key supportive of this hypothesis comes from over-expression regulatory point in protein synthesis (reviewed in Hershey, studies using dominant negative mutants of PKR or a 1991). While there are many proteins that contribute mutated eIF-2 which induced malignant transformation of positively to the translational machinery, one factor that mouse cells (Koromilas et al., 1992; Lengyel, 1993 ; Meurs negatively regulates translation is the interferon-inducible et al., 1993; Barber et al., 1995; Donze et al., 1995) . The double-stranded RNA (dsRNA)-activated protein kinase, direct mechanistic explanation for this observation has PKR. been postulated to be the facilitated translation of mRNAs PKR is found constitutively in low amounts in many encoding growth control genes which are normally eukaryotic cells. Its activity in cells can be potently repressed biosynthetically (reviewed in Sonenberg, 1993) . induced by treatment with interferon α (IFN-α) (Meurs Considering the critical role of PKR in cellular metabolet al., 1990; Tanaka and Samuel, 1994) . PKR is a serine/threonine kinase that has two distinct activities: an ism, cells have presumably developed mechanisms to regulate its activity that are at least as intricate as those genome (vTRBP) were readily detected in cells transfected with each of the respective viral genomes ( Figure 1B ). evolved by viruses. Possibly, multiple factors exist to modulate PKR. In fact, a 58 kDa cellular protein has been Next, the effect of TRBP was compared in parallel treatments of CEM (12D7) cells infected with either described as an inhibitor of PKR autophosphorylation (Lee,T.G. et al., 1990 (Lee,T.G. et al., , 1992 Barber et al., 1994) HIV-1 wild-type or HIV-1 expressing TRBP. Wild-type HIV-1 replication, measured by the production of reverse and a second protein, TAR RNA binding protein (TRBP), has also recently been suggested as a regulator of PKR transcriptase (RT) from infected cells, was inhibited by IFN-α in a dose-dependent manner, with significant effects function (discussed in Gatignol et al., 1993; Park et al., 1994; Blair et al., 1995) . TRBP is a cellular RNA binding observed at 100 and 500 U/ml ( Figure 2A) ; in contrast, replication of HIV-1 TRBP was not affected by IFN-α protein isolated by its ability to bind HIV-1 TAR RNA (Gatignol et al., 1989 (Gatignol et al., , 1991 . Functional studies show that treatment, even at the highest dose of 500 U/ml ( Figure  2B ). One interpretation of these findings is that the antiviral TRBP augments protein expression from the HIV-1 LTR and a number of other viral promoters (HTLV-1LTR, effect mediated through the presumptive activation of PKR by IFN-α is down-modulated by TRBP. Visna LTR and SV40 early promoter; Gatignol et al., 1991) . An RNA binding protein motif in PKR (McCormack et al., 1992) is conserved in TRBP (Gatignol TRBP releases PKR-mediated inhibition of HIV-1 protein synthesis et al., 1993; Kozak et al., 1995) . Thus, in principle, these two proteins would overlap in RNA binding properties.
Introduction
We examined whether the effect of TRBP on IFN-α treatment was at the level of PKR function. Prior studies Indeed, like TRBP, PKR also binds TAR RNA and binding to TAR RNA activates PKR function (Edery et al., 1989;  have established that a major portion of the IFN-α antiviral effect is through PKR activation (reviewed in Samuel, SenGupta and Silverman, 1989; Maitra et al., 1994) .
One mechanism that TRBP might impose on PKR is 1991). Activated PKR differentially influences the translatability of viral mRNAs, thereby selectively affecting to compete for common RNA substrate(s) (Consentino et al., 1995; McCormack and Samuel, 1995) . Here, we replication of viruses such as encephalomyocarditis and vaccinia virus (Meurs et al., 1992; Lee,S.B. et al., 1993) . present evidence for an RNA binding-independent process through which TRBP regulates PKR function in cells. We Experimentally, we assessed if the anti-IFN-α effect of TRBP could be linked to a direct modulation of PKR. show that TRBP and PKR form a hetero-complex through direct protein-protein contact and that this contact prevents
We determined the effect of TRBP on PKR function as measured by inhibition of HIV-1 protein synthesis. PKR-PKR autophosphorylation and PKR-mediated inhibition of viral protein synthesis. We further show that TRBP mediated inhibition of HIV-1 protein synthesis was visualized by immunoblotting using hyperimmune AIDS patient subverts IFN-α activation of PKR, and we define the IFN-α/PKR/TRBP axis as one important intracellular serum ( Figure 3A) . We compared the amount of viral proteins expressed from HeLa cells transfected with the check to cellular proliferation. Disturbance of this critical balance in NIH 3T3 cells through over-expression of infectious genomes individually ( Figure 3A , lanes 5 and 6) or in combination ( Figure 3A , lanes 1-4, 7 and 8), in TRBP results in malignant transformation.
the presence ( Figure 3A , lanes 1, 3, 5 and 7) or absence ( Figure 3A , lanes 2, 4, 6 and 8) of IFN-α. We found that
Results
normalized transfection with pNL alone ( Figure 3A , lane 6) or co-transfection of pNL with pNLTRBP ( Figure 3A , IFN-α treatment inhibits wild-type HIV-1 but not HIV-1 expressing TRBP lane 8) produced large amounts of HIV-1-specific proteins. In contrast, co-transfection of pNL with a pNLPKR Because we are interested in mechanisms regulating virus replication, we investigated the functions of TRBP during genome reduced HIV-1 protein synthesis to undetectable levels ( Figure 3A , lane 4). This suggested that the pNLPKR HIV-1 infections of T cells. Since IFN-α treatment of cells has been shown to repress HIV-1 replication (Francis genome produced functional PKR that inhibited its own expression in cis and the expression of a separate genome et Coccia et al., 1994; Agy et al., 1995; Der and Lau, 1995 ; for a review see Pitha, 1994) and since (pNL) in trans. Interestingly, while pNLPKR was effective on wild-type HIV-1 (pNL; Figure 3A , lane 4), the same this effect is largely attributed to the induction of PKR, we examined the role that TRBP expression might conco-introduction of pNLPKR with pNLTRBP had little effect on the synthesis of HIV-1 proteins ( Figure 3A , lane tribute to this regulated pathway. To assess this in a biologically relevant manner, one needs to synthesize 2). These findings are best explained by a direct role of TRBP ( Figure 3A , lanes 1, 2, 7 and 8) in mitigating PKR TRBP coincidently with peak periods of viral gene expression. We did this by creating an infectious HIV-1 genome inhibition on HIV-1-specific mRNAs. While TRBP effectively counters PKR over-produced in which a TRBP cDNA was expressed in nef ( Figure  1A ). As controls, chimeric viruses ( Figure 1A) were from an exogenous HIV-1 vector (pNLPKR; Figure 3A , lanes 1 and 2), we wondered about the functional ability constructed that express PKR [pNLPKR, a dominant negative PKR mutant with amino acid substitution of of TRBP to interact with endogenous PKR induced by IFN-α treatment (Samuel, 1993; Clemens, 1996) . Hence, arginine for lysine at position 296 (pNLPKR K296R )], TRBP (pNLTRBP) or a TRBP mutant deleted in the critical we compared HIV-1 protein synthesis from cells treated ( Figure 3A , odd numbered lanes) or mock-treated ( Figure  RNA binding domain (pNLTRBP Δ227-270 ; Gatignol et al., 1993) . Transfections were performed using C8166-45 3A, even numbered lanes) with IFN-α (500 U/ml). Indeed, treatment markedly inhibited protein synthesis from wildcells, which do not express detectable amounts of basal PKR activity ( Figure 1B ). Wild-type PKR, the K296R type pNL virus ( Figure 3A , compare lane 6 with 5), however, the same process produced little inhibitory effect mutant of PKR and TRBP expressed from the viral (Adachi et al., 1986) with the wild-type PKR cDNA (pNLPKR), the mutant PKR 296 cDNA (pNLPKR K296R ), the wild-type TRBP cDNA (pNLTRBP) or the mutant TRBP cDNA with deletion of amino acids 227-270 . Cell extracts prepared 24 h after transfection were resolved by SDS-PAGE and analyzed by immunobloting using anti-PKR (lanes 1-4) or anti-TRBP (lanes 5-7). Endogenously expressed TRBP is designated cTRBP (for cellular TRBP) and TRBP expressed by virus is designated vTRBP (for viral TRBP). The difference in size between vTRBP and cTRBP is due to the expression of a shorter cDNA encoding for functional TRBP in the HIV-1 vectors (Blair et al., 1995) . on cells that express or co-express the pNLTRBP genome lymphocytes ( Figure 3D ). We desired to ascertain the effect, if any, that direct over-expression of PKR may ( Figure 3A , lanes 1, 2, 7 and 8). Thus TRBP can function to counter both exogenous PKR (over-expressed from have on HIV-1 spread. Instead of quantifying viral protein synthesis, we monitored the RT growth profiles produced viral vector, pNLPKR; Figure 3A , lanes 1 and 2) and IFN-α-activated endogenous PKR ( Figure 3A , compare by viruses after transfection/co-transfection of infectious genome(s) into replication-permissive 12D7 cells. We lane 5 with 7).
The immunoblot results ( Figure 3A ) were checked found that over-expression of PKR from a pNLPKR virus effectively inhibited in trans wild-type pNL replication with immunoprecipitations using hyperimmune serum of biosynthetically radiolabeled HIV-1 proteins ( Figure 3B ).
for at least 17 days ( Figure 3D , pNL ϩ pNLPKR). In contrast, no inhibition was seen when pNL4-3 was Viral molecular genomes were introduced into cells in the indicated combinations ( Figure 3B ); in each case a introduced into 12D7 cells with a pNLPKR K296R (K296R is a catalytically inactive mutant of PKR) genome (Figure pCMV-β-gal plasmid was also included in order to monitor for transfection efficiency ( Figure 3C ). Half of the cells 3D, pNL ϩ pNLPKR K296R ), confirming that catalytically active PKR mediated the anti-replicative effect. Overin each transfection were analyzed by RNase protection for expressed β-gal mRNA; the results confirmed that the expression of TRBP produced no inherent effects on HIV-1 replication ( Figure 3D , pNL ϩ pNLTRBP). However, six different transfections were comparable in efficiency ( Figure 3C ). Proteins in the other half of the transfected consistent with the HeLa cell findings, we found that a HIV-1 recombinant that expresses TRBP resisted the cells were pulse-labeled with [ 35 S]methionine ϩ cysteine and virus-specific synthesis was visualized by immunootherwise trans-inhibitory effect on replication of a PKRexpressing virus (pNLPKR) ( Figure 3D , pNLPKR ϩ precipitation followed by SDS-PAGE/autoradiography. The results from radiolabeling confirmed the findings pNLTRBP). by immunoblotting ( Figure 3A ). We found that overexpression of PKR potently inhibited HIV-1(pNL)-specific Protein-protein contact between TRBP and PKR Because TRBP contains two dsRNA binding domains protein synthesis ( Figure 3B , lane 4) and that expression of TRBP abrogated this inhibitory activity of PKR (Figure and because dsRNA binding reflects one important step in PKR activation (Samuel, 1993: 3B, lane 6) .
The virological relevance of these molecular findings Clemens, 1996) , one trivial explanation for TRBP-mediated inhibition of PKR is a simple competitive sequestraon viral protein synthesis in HeLa cells ( Figure 3A One explanation is that IFN-α treatment induced a dissociation of the PKR-TRBP complex and that this release is a physiological mechanism of PKR activation. RNase A treatment does leave residual dsRNAs. As such, degradation with this ribonuclease does not strictly exclude the possibility that TRBP-PKR complexes can form through an RNA bridge, where both protein moieties are bound to a common RNA molecule. Hence, we repeated the experiment using cobra venom RNase V1 ( Figure 5 ), which cleaves dsRNA. RNase V1 treatment conditions were optimized by assaying for degradation of predominantly dsRNAs bound to maltose binding protein (MBP)-TRBP fusion protein ( Figure 5A ). Using excess RNase V1, visible RNA signals were essentially eliminated ( Figure 5A , lanes 9-13). Reciprocal co-immunoprecipitations (as in Figure 4 ) were performed on cell extracts thus treated with RNase V1 ( Figure 5B ) and the findings ( Figure 5B , lane 2) were consistent with those in Figure  4 . Taken together, these results are compatible with a direct protein-protein contact between PKR and TRBP that occurs independently of dsRNA.
To check for TRBP-PKR contact using an independent assay, we tested for reconstitution of complexes in vitro. Mutant PKR proteins PKR K296R and PKR K64E/K296R were purified from Escherichia coli as GST fusion proteins. PKR K296K is defective in kinase activity, while PKR K64E/K296R is defective in both kinase activity and dsRNA binding activity (Thomis and Samuel, 1992b; McCormack and Samuel, 1995) . Both forms of PKR 6-10 and 11-15). A control column consisting of GST Cells were maintained in medium containing IFN-α. Virus production protein ( Figure 5C , lanes 1-5) was similarly constructed.
was monitored by supernatant RT assay every 3 days.
Through these columns we passed 1 ml RNase-treated HeLa whole-cell extract. Column flow-throughs (ft, Figure  5C , lanes 1, 6 and 11) were collected, and the columns PKR through direct protein-protein contact. To distinguish between these possibilities, we searched for TRBP-PKR were washed extensively with buffer (20 mM HEPES, pH 7.9, 20 mM KCl, 1 mM MgCl 2 , 2 mM dithiothreitol, 17% complexes in HeLa cells.
Whole HeLa cell extracts were first treated with RNase glycerol; w, Figure 5C , lanes 2, 7 and 12). Bound proteins were then eluted with stepwise increases of NaCl (0.25, A to degrade bulk cellular RNA. The extract was then immunoprecipitated with anti-TRBP (Figure 4 , top) or 0.5 and 1.5 M; Figure 5C , lanes 3-5, 8-10 and 13-15). TRBP retained by column matrices was analyzed by anti-PKR (Figure 4 , bottom) serum. Recovered immunoprecipitates were resolved by SDS-PAGE, then transferred immunoblotting of each eluted fraction. We found that TRBP was eluted from the GST-PKR K296R and from to membrane. The presence of PKR in TRBP-specific immunoprecipitates and the presence of TRBP in PKRthe RNA binding-defective GST-PKR K296R/K64E matrices ( Figure 5C , lanes 8-10 and 13-15), while no TRBP was specific immunoprecipitates were assessed reciprocally by probing membranes with anti-PKR (Figure 4 , top) or antifound in elutions from the GST-alone matrix ( Figure 5C , lanes 3-5). The binding of TRBP to GST-PKR K296R/K64E TRBP (Figure 4, bottom) . In the TRBP-specific immunoprecipitations we visualized PKR (Figure 4 , top, lane 3)
is further consistent with RNA-independent direct proteinprotein contact. and in the PKR-specific immunoprecipitates we found TRBP (Figure 4 , bottom, lane 3). These complementary results suggested that the two proteins formed hetero-
The RNA binding domain of TRBP is not needed for functional interaction with PKR complexes that can be co-immunoprecipitated together from cells.
The RNA-independent biology of PKR-TRBP interaction can be reciprocally assayed using a TRBP mutant IFN-α treatment of HeLa cells induces PKR. We wondered how this treatment might influence PKR-TRBP (TRBP Δ227-270 ) previously characterized to be deficient in RNA binding activity . The binding complex formation. Aliquots of 500 U/ml of IFN-α were added to cells for varying durations (12, 24 and 48 h; phenotype of TRBP Δ227-270 is biochemically illustrated in Figure 6A . While MBP-TRBP fusion protein ( Figure  Figure 4 , lanes 4-6) and then we performed reciprocal Half of the cells from the transfection described in (B) were analyzed by RNase protection assay using a probe for β-galactosidase RNA. Lanes 1-6 correspond to the same numbered lanes as in (B). Lane 7 contains intact input probe. Lane 8 contains molecular size markers consisting of 32 P-endlabeled pBR322 HpaII fragments. The lower arrow points to β-galactosidase mRNA signal protected from RNase digestion. (D) 12D7 cells were transfected with pNL (n) and co-transfected with pNL and pNLPKR (e), pNL and pNLPKR K296R (r), pNL and pNLTRBP (s) or pNLPKR and pNLTRBP (j). Virus production was monitored by supernatant RT assay every 3 days.
6A, lanes 7-10) bound radiolabeled total cellular RNA individually with pNL ( Figure 6B , lane 1), pNLTRBP ( Figure 6B , lane 2), pNLTRBP Δ227-270sense ( Figure 6B , efficiently, MBP-TRBP Δ227-270 ( Figure 6A, lanes 11-14) , like MBP alone ( Figure 6A , lanes 3-6), showed no affinity lane 3) or pNLTRBP Δ227-270antisense ( Figure 6B , lane 4). Each transfection produced similar amounts of HIV-1-for RNA.
Next, we checked functionally how RNA bindingspecific expression, as measured by release of viral RT into the culture supernatant. Combinations of pNL defective TRBP protein might influence PKR-mediated inhibition of HIV-1 expression. We transfected HeLa cells and pNLTRBP ( Figure 6B , lane 5), pNL and examine how such treatment might affect the basal expression of PKR and TRBP. We treated HeLa cells with 500 U/ml IFN-α. Extracts from mock-treated HeLa cells or cells treated for 12 or 24 h were prepared and resolved by SDS-PAGE. The amount of PKR/TRBP in each extract was analyzed by immunoblotting using anti-PKR ( Figure  7A ) or anti-TRBP ( Figure 7B ) serum. We observed an inverse correlation. Treatment of HeLa cells with IFN-α up-regulated steady-state levels of PKR ( Figure 7A ) and down-regulated the steady-state amount of TRBP ( Figure  7B ). Mechanistically, this suggests that IFN-α alters the intracellular stoichiometry of PKR and TRBP and that such change adversely affects the formation of PKR-TRBP hetero-complexes. PKR activity can be regulated at many levels, including repression of gene transcription and modulation of 1-3) or HeLa cells treated with IFN-α (500 U/ml) (Cosentino et al., 1995; Patel et al., 1995; Ortega et al., Figure 8B ) for an effect of over-expressed wild-type PKR described in the above experiments. In comparison, no such inhibition additional 8 h. Equivalent count-containing samples were prepared and immunoprecipitated using anti-PKR antiwas seen when pNL and a pNL virus that expresses a catalytically inactive PKR mutant (pNLPKR K296R ) were body. The immunoprecipitates were resolved by SDS-PAGE and PKR-specific 68 kDa protein was visualized co-transfected into cells ( Figure 6B, lane 9) . Introduction of pNLPKR together with a pNL virus that expresses wildby phosphorimaging. We found that compared with mock-treated cells, cells type TRBP (pNLTRBP) produced, as expected, normal amounts of RT ( Figure 6B, lane 10) . Intriguingly, and treated with IFN-α modestly increased (4-fold) the amount of 35 S-labeled PKR ( Figure 8B , compare lane 6 with 5), perhaps somewhat unexpectedly, the simultaneous presence of pNLPKR virus with pNLTRBP Δ227-270sense virus however, the same treatment resulted in a larger (9-fold) increase in 32 P-labeled PKR ( The HeLa cell results ( Figure 6B ) were replicated with and 2), such treatment failed to elicit much increase (1.5-fold) in 32 P-labeled PKR ( Figure 8A, lanes 1 and 2) . virus growth assays in T lymphocytes (Figures 6C and  D) . In the latter setting, viral growth was monitored over These results suggest that one primary level of TRBP action is to influence PKR phosphorylation. a period of 17 days after transfection of the indicated genomes, alone or in combination, into 12D7 cells. We
To determine whether inhibition of PKR autophosphorylation was a direct effect of TRBP, we reconstituted followed the spread of virus by plotting the amount of viral RT released from infected cells. From the RT profiles this finding in vitro ( Figure 8C ). We immunoprecipitated PKR from HeLa cells and incubated this preparation with ( Figure 6C and D) it was evident that with respect to PKR activity, in the setting of replicating viruses, RNA binding-MBP ( Figure 8C , lane 1) or a MBP-TRBP fusion ; Figure 8C , lanes 2 and 3) or buffer alone deficient TRBP Δ227-270 functioned like wild-type RNA binding-competent TRBP.
(none; Figure 8C , lane 4). In vitro autophosphorylation of immunoprecipitated PKR in each of these incubations was commenced by adding 1 μg/ml poly(I)·poly(C) with IFN-α-regulated expression of TRBP and PKR The suggestion that IFN-α might modulate TRBP-PKR 100 μCi/ml [γ-32 P]ATP for 20 min at 30°C. The resulting phosphorylated moieties were resolved by SDS-PAGE complex formation (Figures 4 and 5) prompted us to The radiolabeled RNA was equilibrated with bead-bound MBP-TRBP, as described in Materials and methods. The beads were divided into two aliquots which were mock-treated (lanes 4-8) or treated with RNase V1 (lanes 9-13). After RNase treatment, bound RNAs were eluted in a stepwise fashion using binding buffer containing 0.5 M (lanes 4 and 9), 1.0 M (lanes 5 and 10), 1.5 M (lanes 6 and 11), 2.0 M (lanes 7 and 12) or 2.5 M (lanes 8 and 13) NaCl. Eluted RNAs were concentrated by ethanol precipitation and visualized in a denaturing 6% polyacrylamide gel. Lane 1 contains molecular size markers. Total 32 P-labeled RNA isolated from H9 cells that were mock-treated (lane 2) or treated with RNase V1 (lane 3) is shown. (B) Co-immunoprecipitation of PKR and TRBP after treatment of cell extract with RNase V1. Immunoprecipitations followed by Western blotting were performed as described in Figure 4 , except that the extracts were treated with RNase V1 prior to immunoprecipitation. (C) Protein column chromatography demonstrates an interaction between TRBP and a PKR mutant (K64E/K296R) defective for dsRNA binding. PKR mutants K296R and K64E/K296R were produced in E.coli as GST fusion proteins (GST-PKR K296R and GST-PKR K64E/K296R ). GST-PKR K296R , GST-PKR K64E/K296R or GST alone were saturated on glutathione-Sepharose beads. Extracts from HeLa cells were separately equilibrated overnight at 4°C with each of the three protein-bound beads. After this incubation, the beads were washed several times with buffer (20 mM HEPES, pH 7.9, 20 mM KCl, 1 mM MgCl 2 , 17% glycerol, 2 mM dithiothreitol; lanes 2, 7 and 12). Washed beads were eluted with stepwise increases of NaCl (0.25 M, lanes 3, 8 and 13; 0.5 M, lanes 4, 9 and 14; 1.5 M, lanes 5, 10 and 15). The presence of TRBP in the eluates were assessed by Western blotting using anti-TRBP polyclonal antibody. Lane ft, 'flow through' after equilibration with beads. and incorporation of 32 P was visualized by autoradiography growth (Sonenberg, 1993) . In principle, a perturbation of this homeostasis might contribute adversely to cellular ( Figure 8C ). We found MBP-TRBP ( Figure 8C , lanes 2 and 3) but not MBP ( Figure 8C , lane 1) nor buffer alone proliferation. Indeed, it has been shown that NIH 3T3 cells engineered to over-express an exogenous PKR mutant ( Figure 8C , lane 4) in the reactions efficiently prevented PKR autophosphorylation. The experiment shown in (a substitution of Lys296 with arginine or proline, PKR296) produced tumors rapidly when injected into nude mice. Figure 8C was repeated substituting MBP-TRBP Δ227-270 in place of MBP-TRBP ( Figure 8D ). In this phosphorylation Thus, mechanistically, a disturbance of the PKR translational control (Koromilas et al., 1992; Lengyel, 1993 ; assay, the RNA binding-defective TRBP Δ227-270 again exhibited the same phenotype as RNA binding-competent Meurs et al., 1993; Donze et al., 1995) is sufficient to account for cellular transformation. By analogy, we queried wild-type TRBP.
whether TRBP, when over-expressed, would transform NIH 3T3 cells by inhibiting PKR activity.
Over-expression of TRBP morphologically transforms NIH 3T3 cells
NIH 3T3 cells were selected for expression of pCMVTRBP or expression of neo alone (Figure 9 ). These An increasing number of biological examples illustrates the critical role of translational control in homeostatic cell cells were subjected to morphological and functional com- parisons. We examined three growth criteria: (i) contact 10 and Table I ). In comparison, none of the five mice injected with NIH 3T3-neo cells and one of five mice injected with inhibition; (ii) anchorage-independent growth; (iii) tumor formation in animals. NIH 3T3 cells expressing TRBP NIH 3T3 cells developed tumors ( Figure 10 and Table I ). Considered together with the tissue culture results ( Figure  (Figure 9B , D and F) were found to exhibit characteristics consistent with transformation, including loss of contact 9), these findings indicate that TRBP has an in vivo role as a regulator of PKR function and that dysregulated cellular inhibition ( Figure 9D ) and colony formation in soft agar ( Figure 9F ). In comparison, NIH 3T3 cells (data not shown) growth is one consequence of TRBP over-expression. and NIH 3T3-neo cells were contact inhibited and failed to grow into sizable colonies in soft agar ( Figure 9C and E). discussion, studies by others (Edlin et al., 1992; Francis et al., 1992; Coccia et al., 1994 ; for a review see Pitha, 1994) make it clear that IFN-α, in various settings, suppresses productive HIV-1 infection of permissive cells. Unquestionably, there are PKR-independent pathways in cells through which IFN-α signals are transduced (for a review see Williams, 1991) . Our findings here establish a tight correlation between IFN-α and PKR in biosynthetically repressing HIV-1 protein synthesis and replication (Figures 2-6 ).
Discussion
The linkage between PKR and IFN-α was largely established using TRBP. TRBP is an HIV-1 TAR RNA binding protein that shares a dsRNA binding motif Kozak et al., 1995) with PKR (McCormack et al., 1992) . Given this commonality in RNA binding and given that TRBP is highly conserved across species and expressed in all tissues (Kozak et al., 1995) , it was reasonable to suppose that TRBP and PKR could compete in cells for binding to the same substrate (lanes 1 and 2) or HeLa cells expressing pCMVTRBPa (lanes 3 and 4) were treated (lanes 2, 4 and 6) or mockboth TRBP (Gatignol et al., 1991) infections of T lymphocytes, TRBP has a potent ability to counter the inhibition of viral protein synthesis mediated by PKR (Figures 3 and 6 ). This finding agrees with and (Lee,T.G. et al., 1990 (Lee,T.G. et al., , 1992 Barber et al., 1994) , a 15 kDa 3T3-F442A cell protein (Judware and Petryshyn, extends the in vitro reporter assays previously reported by Park et al. (1994) . It also suggests that TRBP belongs 1991) and a Ras-inducible inhibitory factor from KBALB cells (Mundschau and Faller, 1992) . functionally to a class of cellular inhibitors of PKR (reviewed in Lee,T.G. and Katze, 1994 ) that includes p58
Details on how cellular inhibitors of PKR function are similar to protein-mediated formation of PKR homodimer (Patel et al., 1995; Ortega et al., 1996) . One study (Cosentino et al., 1995) has suggested that the binding of dsRNA by PKR is necessary for homodimerization with PKR itself or heterodimerization with TRBP. This conclusion was largely based on the results of far-Western and yeast two-hybrid analyses using a PKR fusion protein possessing a large deletion (residues 1-97 and 104-157 deleted). In contrast, other investigators have concluded, from studies utilizing various mutant PKR constructs which lack RNA binding activity, that the dimerization of PKR is RNA independent, both when measured in vivo (in yeast or COS cells by two-hybrid analyses) or in vitro by affinity chromatography and electrophoretic mobility shift analyses (Patel et al., 1995; Ortega et al., 1996) . The differences between Cosentino et al. and the other groups (Patel et al., 1995; Ortega et al., 1996) most likely derive from the nature of the assays employed and the conformational form of the PKR protein examined. Perhaps an RNA bridge may indeed mediate dimerization in the absence of the protein domain of a subset of cellular genes (Petryshyn et al., 1984;  (C and D) cells maintained in culture for 5 days after reaching confluency. (E and F) Anchorage-independent growth of NIH 3T3-neo Chong et al., 1992; Dever et al., 1993; Lee,S.B. et al., (E) and NIH 3T3 TRBPneo (F) in soft agar.
1993; Lee and Esteban, 1994 ; for a review see Williams, 1991) , thus, the commonly described anti-viral effects of PKR are probably secondary manifestations. In this regard, states (Koromilas et al., 1992; Lengyel, 1993; Meurs et al., 1993; Donze et al., 1995) . More recently, independent confirmation of transformation was achieved by overnot fully understood. We find that TRBP exerts its effects, at least in part, through formation of a hetero-complex expressing p58, a cellular inhibitor of PKR (Lee,T.G. et al., 1990 (Lee,T.G. et al., , 1992 Barber et al., 1994) . Mechanwith PKR in an RNA binding-independent manner. Three lines of experimentation are consistent with this proposiistically, this effect on cellular proliferation can be explained by a disturbance in the balanced regulation of tion. First, direct immunoprecipitation from cellular extracts that were first treated with RNase A and/or RNase translation of certain growth-related mRNAs (reviewed in Sonenberg, 1993) . Indeed, findings from mutations in V1 showed that TRBP is recovered using anti-PKR serum and PKR is recovered using anti-TRBP serum (Figures 4 other elements of the translational machinery support this notion (Donze et al., 1995) . Although no evidence of and 5). This supports the idea that the two proteins exist as a complex in cells. Second, TRBP binds directly to tumor suppressor acitivity of PKR was observed in studies of 'knock-out' mice devoid of functional PKR (Yang column matrices containing GST-PKR K296R or GST-PKR K296R/K64E , but not to one containing GST alone et al., 1995) , it is conceivable that another form of functional eIF-2α protein kinase (Chen et al., 1991; (Figure 5C) . We note that GST-PKR K296R/K64E is a form of PKR deficient for dsRNA binding activity (McCormack Samuel, 1993) remained in the PKR -/-animals which complemented in part the PKR deficiency. McCormack and Samuel, 1995) . The finding that TRBP binds GST-PKR K296R/K64E suggests that the Our results on TRBP provide further support for the critical role of PKR in cellular proliferation. We found two proteins contact each other directly and are not indirectly tethered via a bridging dsRNA molecule. Third, that over-expression of TRBP results in loss of contact inhibition, production of anchorage-independent growth an RNA binding-defective TRBP mutant (TRBP Δ227-270 ) behaved like wild-type TRBP in effective biochemical and progression to tumor formation when injected into animals ( Figures 9 and 10 and Table I ). Because, at the ( Figure 8D ) functional ( Figure 6B ) interactions with PKR. Taken together, these results strongly suggest that TRBP protein level, TRBP is completely different from p58 and is insignificantly similar to trans-dominant mutant PKRs forms a protein-mediated complex with PKR in a manner washed twice with medium before resuspending in medium at a density (tmPKRs) and because the one property common to the of 5ϫ10 5 cells/ml. three proteins (TRBP, p58 and tmPKRs) is functional inhibition of wild-type PKR, one can reasonably deduce
Reverse transcriptase assay
that PKR is the linchpin in the three discrete approaches
Reverse transcriptase assays were performed as previously described to transformation. Growth controls like that engendered (Huang et al., 1994) . Each reaction contained 5 μl viral supernatant in 50 μl RT cocktail [60 mM Tris, pH 8, 75 mM KCl, 5 mM MgCl 2 , 0.1% by PKR represent important checks to general cellular Nonidet P-40, 1 mM EDTA, 5 μg/ml poly(rA), 0.16 μg/ml oligo(dT), metabolism. In other biological systems critical check-[α-32 P]dTTP (1 μCi/ml)] and was incubated at 37°C for 1 h. For each points are commonly redundant (for a review see Hunter, reaction 5 μl was spotted onto DEAE paper which was washed four 1995). A recent mouse 'knock-out' study (Yang et al., times in 2ϫ SSC, dried and analyzed using a Fuji phosphorimager.
1995) provides some indication that developmentally this might also be the case for PKR.
Antibodies
Anti-PKR and anti-TRBP polyclonal antibodies were as previously From the perspective of HIV-1, we find it intriguing described (Thomis and Samuel, 1992a,b; Gatignol et al., 1993) . HIV-1 that TRBP is a potent counter to PKR. Viruses clearly hyperimmune serum was from an AIDS patient.
have a vested interest in evolving escape strategies from the antiviral effects of PKR (reviewed in Protein analysis and some viruses are more accomplished at this than tions (Tropix; .
For immunoprecipitation, identical amounts of protein were suspended in 1 ml RIPA buffer and incubated for 2 h at 4°C with antiserum. Protein
Materials and methods
A-Sepharose (Pharmacia) was added to each sample followed by 1 h incubation at 4°C, with several washings in RIPA buffer. The Plasmids immunoprecipitated products were then solubilized in loading buffer All proviral constructs were derived from the parental pNL4-3 infectious (125 mM Tris, pH 6.8, 20% glycerol, 2% SDS, 2% β-mercaptoethanol, molecular clone (Adachi et al., 1986) . Insertions of cDNA into nef have 0.01% bromophenol blue) and resolved by SDS-PAGE. been described elsewhere (Joshi and Jeang, 1993; Huang et al., 1994) . The PKR cDNA, PKR K296R and PKR K296R/K64E have been described previously (Thomis and Samuel, 1992a,b; McCormack et al., 1994;  PKR phosphorylation Cells (5ϫ10 6 ) were mock-treated or treated with IFN-α (500 U/ml) for McCormack and Samuel, 1995) . TRBP and TRBP Δ227-270 have been described .
12 h, washed in PBS and then resuspended in 2 ml phosphate-free DMEM or methionine-and cysteine-free DMEM medium. [ 32 P]Orthophosphate (500 μCi/sample) or a mixture of [ 35 S]methionine ϩ cysteine Cell culture, transfection and infection HeLa cells and NIH 3T3 cells were propagated in Dulbecco's modified (Translabel; ICN Biomedicals) (200 μCi/sample) was added to each 2 ml suspension of cells. After 8 h incubation at 37°C, the cells were Eagle's medium (DMEM) with 10% fetal bovine serum (FBS). Continuous suspensions of human CEM (12D7) cells and continuous washed in PBS and resuspended in RIPA buffer. For in vitro phosphorylation, PKR was purified from 1ϫ10 6 HeLa suspensions of C8166-45 T-cells were grown in RPMI 1640 with 10% FBS. Transfections of HeLa and NIH 3T3 cells were performed using cells using specific polyclonal antibody with protein A-Sepharose and assayed for protein kinase activity as previously described (Hovanessian calcium phosphate. Aliquots of 10 μg total HIV-1 genome were used for each transfection. Electroporation (Bio-Rad) of 5ϫ10 6 suspension et al., 1987) . Briefly, immune complex preparations were incubated in 20 μl buffer (20 mM HEPES, pH 7.5, 50 mM potassium chloride, 5 mM cells in 300 μl 1ϫ phosphate-buffered saline (PBS) using 20 μg total HIV-1 genome was performed at a setting of 250 V and 960 μF.
2-mercaptoethanol, 1.5 mM manganese chloride, 1.5 mM magnesium chloride) containing poly(I)·poly(C) (1 μg/ml) and 2 mM [γ-32 P]ATP Virus stocks were prepared from supernatants of transfected HeLa cells and were quantified by RT activity. For infection of CEM (12D7) (50 Ci/mmol) at 30°C for 20 min. Plasmid pBS-TRBP, encoding TRBP fused to MBP, has been described (Gatignol et al., 1991) . MBP-TRBP, cells, 1ϫ10 6 cells were incubated with virus for 1 h at 37°C and then MBP-TRBP Δ227-270 and MBP were produced in E.coli XL1 Blue as eukaryotic initiation factor 2α (eIF-2α) kinase of rabbit reticulocytes: previously described (Gatignol et al., 1991 The vaccinia virus K3L gene product potentiates translation by for 30 min at room temperature with 10 U/ml RNase V1 (Pharmacia).
inhibiting double-stranded-RNA-activated protein kinase and Additional washes were performed and the bound RNAs were eluted as phosphorylation of the alpha subunit of eukaryotic initiation factor 2. described above.
J. Virol., 66, 1943 -1950 . Der,S.D. and Lau,A.S. (1995 Involvement of the double-strandedRNase protection asssay RNA-dependent kinase PKR in interferon expression and interferonTotal RNA from transfected HeLa cells was extracted using a RNAzol mediated antiviral activity. Proc. Natl Acad. Sci. USA, 92, 8841-8845. extraction kit. The RNase protection assay was performed according to Dever,T.E., Chen,J.J., Barber,J.N., Cigan,A.M., Feng,L., Donahue,T.F., protocol suggested by the manufacturer (RPA II kit; Ambion).
London,I.M., Katze,M.G. and Hinnebusch,A.G. (1993) 
